Loss of P16 Expression and Chromosome 9p21 LOH in Predicting Outcome of Patients Affected by Superficial Bladder Cancer

Journal of Surgical Research

Volumn 143, Issue 2, 2007, Pages 422-427

  Bartoletti, Riccardo ^a   Cai, Tommaso ^a   Nesi, Gabriella ^a   Roberta Girardi, Lucia ^a   Baroni, Gianna ^a   Dal Canto, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

chromosome 9; LOH; microsatellite analysis; p16; urothelial cancer

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CHROMOSOME 21; CHROMOSOME 9P; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; SUPERFICIAL CANCER; UROTHELIUM;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; KAPLAN-MEIERS ESTIMATE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 36148957497     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.01.012     Document Type: Article

References (30)

1. Mhawech-Fauceglia P., Cheney R.T., and Schwaller J. Genetic alterations in urothelial bladder carcinoma: An update review. Cancer 106 (2006) 1205
2. Stein J.P., Grossefeld G.D., Ginsberg D.A., et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 160 (1998) 645
3. Wada T., Louhelainen J., Hemminki K., et al. The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction. BJU Int 87 (2001) 876
4. Stadler W.M., Sherman J., Bohlander S.K., et al. Homozygous deletions within chromosomal bands 9p21δ22 in bladder cancer. Clin Cancer Res 54 (1994) 2060
5. Stadler W.M., Steinberg G., Yang X., et al. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Clin Cancer Res 7 (2001) 1676
6. Simon R., Burger H., Brinkschmidt C., et al. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 185 (1998) 345
7. Devin K., Keen A.J., and Knowles M.A. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA. Oncogene 9 (1994) 2757
8. Cairns P., Shaw M.E., and Knowles M.A. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 53 (1993) 1230
9. Bartoletti R., Cai T., Dal Canto M., et al. Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: A rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma. J Urol 175 (2006) 2032
10. Chapman E.J., Harnden P., Chambers P., et al. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous codeletion and association with clinical phenotype. Clin Cancer Res 11 (2005) 5740
11. Hitchings A.W., Kumar M., Jordan S., et al. Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16, and pRb. Br J Cancer 91 (2004) 552
12. Cheng L., MacLennan G.T., Zhang S., et al. Laser capture microdissection analysis reveals frequent allelic loss in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 101 (2004) 183
13. Jones T.D., Carr M.D., Eble J.N., et al. Clonal origin of lymph node metastases in bladder carcinoma. Cancer 104 (2005) 1901
14. Orlow I., Lacombe L., Hannon G.J., et al. Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst 87 (1995) 1524
15. Friedrich M.G., Blind C., Milde-Langosch K., et al. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence. Eur Urol 40 (2001) 518
16. Bartoletti R., Dal Canto M., Cai T., et al. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Oncol Rep 13 (2005) 531
17. Dal Canto M., Bartoletti R., Travaglini F., et al. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma. Anticancer Res 23 (2003) 5095
18. McCarthy R.P., Zhang S., Bostwick D.G., et al. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phylloides tumor of the prostate. Am J Pathol 165 (2004) 1395
19. UICC International Union Against Cancer. TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York, NY 199
20. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Histological typing of urinary bladder tumors. Geneva World Health Organization, 1973. Am J Surg Pathol 22 (1998) 1435
21. Oosterlinck W., Lobel B., Jakse G., et al. The EAU Working Group on Oncological Urology: Guidelines on Bladder Cancer. Eur Urol 41 (2002) 105
22. Tada Y., Wada M., Taguchi K., et al. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Cancer Res 62 (2002) 4048
23. Chang L.L., Yeh W.T., Yang S.Y., et al. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J Urol 170 (2003) 595
24. Wolff E.M., Liang G., and Jones P.A. Mechanisms of disease: Genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2 (2005) 502
25. Swellam M., El-Aal A., and Abugabel K.M. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-α expression. Clin Biochem 37 (2004) 1098
26. ARF methylation as a potential biomarker for human bladder cancer. Biochem Biophys Res Commun 339 (2006) 790
27. Orlow I., LaRue H., Osman I., et al. Deletions of the INK4a gene in superficial bladder tumors. Association with recurrence. Am J Pathol 155 (1999) 105
28. Krüger S., Mahnken A., Kausch I., et al. p16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. Eur Urol 47 (2005) 463
29. Sardi I., Dal Canto M., Bartoletti R., et al. Abnormal c-myc oncogene DNA methylation in human bladder cancer: Possible role in tumor progression. Eur Urol 31 (1997) 224
30. Kondo T., Ezzat S., and Asa S.L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6 (2006) 292